Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

This study has been completed.
Archimedes Development Ltd
Information provided by:
Pharmalink AB Identifier:
First received: October 5, 2008
Last updated: April 20, 2009
Last verified: April 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)